Avricore Health Inc.
Avricore Health Inc. (AVCR.V) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
avcr.v · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Avricore Health Inc. (AVCR.V) measures how much investors pay for each dollar of the company's trailing earnings. AVCR.V's current PE ratio of N/A is calculated by dividing its stock price of $0.05 by its TTM earnings per share of -$0.02.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2007 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Diagnostics & Research · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Avricore Health Inc.You AVCR.V | $5M | N/A | — | -$0.02 |
 Aptose Biosciences Inc. APS.TO | $6M | N/A | — | -$10.59 |
 CanadaBis Capital Inc. CANB.V | $2M | N/A | — | -$0.01 |
 CordovaCann Corp. CDVA.CN | $4M | N/A | — | -$0.02 |
 Kane Biotech Inc. KNE.V | $5M | N/A | — | -$0.02 |
 Mercanto Holdings Inc. MUSH.V | $6M | N/A | — | -$0.01 |
 Mountain Valley MD Holdings Inc. MVMD.CN | $25M | N/A | — | -$0.02 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.02 | — | |
2024-12-31 FY2024 | — | $-0.01 | — | |
2023-12-31 FY2023 | — | $-0.01 | — | |
2022-12-31 FY2022 | — | $-0.01 | — | |
2021-12-31 FY2021 | — | $-0.02 | — | |
2020-12-31 FY2020 | — | $-0.02 | — | |
2019-12-31 FY2019 | — | $-0.04 | — | |
2018-12-31 FY2018 | — | $-0.12 | — | |
2017-12-31 FY2017 | — | $-0.15 | — | |
2016-12-31 FY2016 | — | $-0.18 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Avricore Health Inc. (AVCR.V) measures how much investors pay for each dollar of the company's trailing earnings. AVCR.V's current PE ratio of N/A is calculated by dividing its stock price of $0.05 by its TTM earnings per share of -$0.02.
Frequently asked questions
AVCR.V pe ratio · 6 questionsAVCR.V's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.05 and TTM EPS of -$0.02. Data sourced from Financial Modeling Prep via AVCR.V's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Avricore Health Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08